Benjamin Edwards Inc Charles River Laboratories International, Inc. Transaction History
Benjamin Edwards Inc
- $6.78 Billion
- Q4 2024
A detailed history of Benjamin Edwards Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Benjamin Edwards Inc holds 1,485 shares of CRL stock, worth $261,241. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,485
Previous 1,451
2.34%
Holding current value
$261,241
Previous $285,000
3.86%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CRL
# of Institutions
710Shares Held
53.9MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$1.08 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$895 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$717 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$384 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$318 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.95B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...